Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2020 Dec 9

PMID 33291236

Citations 34

Authors

Tapan Behl

Aditi Sharma

Lalit Sharma

Aayush Sehgal

Gokhan Zengin

Roxana Brata

Ovidiu Fratila

Simona Bungau

Affiliations

Soon will be listed here.

Abstract

Withaferin A (WA), a manifold studied, C28-steroidal lactone withanolide found in . Given its unique beneficial effects, it has gathered attention in the era of modern science. Cancer, being considered a "hopeless case and the leading cause of death worldwide, and the available conventional therapies have many lacunae in the form of side effects. The poly pharmaceutical natural compound, WA treatment, displayed attenuation of various cancer hallmarks by altering oxidative stress, promoting apoptosis, and autophagy, inhibiting cell proliferation, reducing angiogenesis, and metastasis progression. The cellular proteins associated with antitumor pathways were also discussed. WA structural modifications attack multiple signal transduction pathways and enhance the therapeutic outcomes in various diseases. Moreover, it has shown validated pharmacological effects against multiple neurodegenerative diseases by inhibiting acetylcholesterinases and butyrylcholinesterases enzyme activity, antidiabetic activity by upregulating adiponectin and preventing the phosphorylation of peroxisome proliferator-activated receptors (PPARγ), cardioprotective activity by AMP-activated protein kinase (AMPK) activation and suppressing mitochondrial apoptosis. The current review is an extensive survey of various WA associated disease targets, its pharmacokinetics, synergistic combination, modifications, and biological activities.

Citing Articles

Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection.

Sharma K, Subramani C, Ganesh K, Sharma A, Basu B, Balyan S PLoS Pathog. 2025; 20(12):e1012816.

PMID: 39775571 PMC: 11723598. DOI: 10.1371/journal.ppat.1012816.

Vimentin modulates regulatory T cell receptor-ligand interactions at distal pole complex, leading to dysregulated host response to viral pneumonia.

Ma R, Prigge A, Ortiz Serrano T, Cheng Y, Davis J, Lou K Cell Rep. 2024; 43(12):115056.

PMID: 39645657 PMC: 11804169. DOI: 10.1016/j.celrep.2024.115056.

Current mechanistic insights into Withaferin A: a promising potential adjuvant anticancer agent from Withania somnifera.

Nisar M, Wan C, Busselberg D, Calina D, Sharifi-Rad J Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39614896 DOI: 10.1007/s00210-024-03662-y.

Quantifying Withanolides in Plasma: Pharmacokinetic Studies and Analytical Methods.

Speers A, Lozano-Ortiz A, Soumyanath A Nutrients. 2024; 16(22).

PMID: 39599622 PMC: 11597739. DOI: 10.3390/nu16223836.

Explication of Pharmacological Proficiency of Phytoconstituents from Bark: An and Approaches.

P S, S G, Kt N, Selvaraj C, K L Scientifica (Cairo). 2024; 2024:6645824.

PMID: 39184813 PMC: 11343629. DOI: 10.1155/2024/6645824.

References

Rathmann W, Giani G . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(10):2568-9. DOI: 10.2337/diacare.27.10.2568. View

Sanchez-Martin M, Ambesi-Impiombato A, Qin Y, Herranz D, Bansal M, Girardi T . Synergistic antileukemic therapies in -induced T-ALL. Proc Natl Acad Sci U S A. 2017; 114(8):2006-2011. PMC: 5338362. DOI: 10.1073/pnas.1611831114. View

Palliyaguru D, Chartoumpekis D, Wakabayashi N, Skoko J, Yagishita Y, Singh S . Withaferin A induces Nrf2-dependent protection against liver injury: Role of Keap1-independent mechanisms. Free Radic Biol Med. 2016; 101:116-128. PMC: 5154810. DOI: 10.1016/j.freeradbiomed.2016.10.003. View

Zhao J, Zhang L, Dong X, Liu L, Huo L, Chen H . High Expression of Vimentin is Associated With Progression and a Poor Outcome in Glioblastoma. Appl Immunohistochem Mol Morphol. 2016; 26(5):337-344. DOI: 10.1097/PAI.0000000000000420. View

Cohen S, Mukerji R, Timmermann B, Samadi A, Cohen M . A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. Am J Surg. 2012; 204(6):895-900. DOI: 10.1016/j.amjsurg.2012.07.027. View

Monastyrska I, Rieter E, Klionsky D, Reggiori F . Multiple roles of the cytoskeleton in autophagy. Biol Rev Camb Philos Soc. 2009; 84(3):431-48. PMC: 2831541. DOI: 10.1111/j.1469-185X.2009.00082.x. View

Brenner D, Waterboer T, Choi S, LINDQUIST J, Stefanovic B, Burchardt E . New aspects of hepatic fibrosis. J Hepatol. 2000; 32(1 Suppl):32-8. DOI: 10.1016/s0168-8278(00)80413-4. View

Farrell G, Larter C . Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006; 43(2 Suppl 1):S99-S112. DOI: 10.1002/hep.20973. View

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z . Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020; 10(6):783-791. PMC: 7309152. DOI: 10.1158/2159-8290.CD-20-0422. View

10.

Huang M, He J, Hu H, Zhang K, Wang X, Zhao B . Withanolides from the genus Physalis: a review on their phytochemical and pharmacological aspects. J Pharm Pharmacol. 2019; 72(5):649-669. DOI: 10.1111/jphp.13209. View

11.

Su H, Weng C, Hsiao P, Chen L, Kuo T, Chen Y . Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Mol Cancer Res. 2013; 11(7):768-79. DOI: 10.1158/1541-7786.MCR-12-0511. View

12.

Muniraj N, Siddharth S, Nagalingam A, Walker A, Woo J, Gyorffy B . Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells. Carcinogenesis. 2019; 40(9):1110-1120. PMC: 10893887. DOI: 10.1093/carcin/bgz015. View

13.

Zhang L, Nemzow L, Chen H, Lubin A, Rong X, Sun Z . The deubiquitinating enzyme USP24 is a regulator of the UV damage response. Cell Rep. 2015; 10(2):140-7. PMC: 4359050. DOI: 10.1016/j.celrep.2014.12.024. View

14.

Santagata S, Xu Y, Wijeratne E, Kontnik R, Rooney C, Perley C . Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol. 2011; 7(2):340-9. PMC: 3291478. DOI: 10.1021/cb200353m. View

15.

Ormanns S, Neumann J, Horst D, Kirchner T, Jung A . WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling. Oncotarget. 2014; 5(10):2999-3011. PMC: 4102786. DOI: 10.18632/oncotarget.1626. View

16.

Patil D, Gautam M, Mishra S, Karupothula S, Gairola S, Jadhav S . Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract. J Pharm Biomed Anal. 2013; 80:203-12. DOI: 10.1016/j.jpba.2013.03.001. View

17.

Sy-Cordero A, Graf T, Runyon S, Wani M, Kroll D, Agarwal R . Enhanced bioactivity of silybin B methylation products. Bioorg Med Chem. 2012; 21(3):742-7. PMC: 3630461. DOI: 10.1016/j.bmc.2012.11.035. View

18.

Cragg G, Newman D . Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013; 1830(6):3670-95. PMC: 3672862. DOI: 10.1016/j.bbagen.2013.02.008. View

19.

Wang L, Huang X, Zheng X, Wang X, Li S, Zhang L . Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy. Int J Biol Sci. 2013; 9(5):472-9. PMC: 3677682. DOI: 10.7150/ijbs.5855. View

20.

Naghibi F, Esmaeili S, Abdullah N, Nateghpour M, Taghvai M, Kamkar S . In vitro and in vivo antimalarial evaluations of myrtle extract, a plant traditionally used for treatment of parasitic disorders. Biomed Res Int. 2014; 2013:316185. PMC: 3885200. DOI: 10.1155/2013/316185. View